Shiyan Dong

2.1k total citations · 2 hit papers
34 papers, 1.3k citations indexed

About

Shiyan Dong is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Shiyan Dong has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Biomaterials and 9 papers in Biomedical Engineering. Recurrent topics in Shiyan Dong's work include RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (10 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Shiyan Dong is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (10 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Shiyan Dong collaborates with scholars based in China, United States and Singapore. Shiyan Dong's co-authors include Lesheng Teng, Zhaogang Yang, Robert J. Lee, Jing Xie, Ye Bi, Huan Zhang, Wen Jiang, Betty Y.S. Kim, Yifan Ma and Jinqiao Wang and has published in prestigious journals such as Nature Communications, ACS Nano and Nature Nanotechnology.

In The Last Decade

Shiyan Dong

32 papers receiving 1.3k citations

Hit Papers

Cell-Penetrating Peptides in Diagnosis and Treatment of H... 2020 2026 2022 2024 2020 2025 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiyan Dong China 20 744 360 359 182 123 34 1.3k
Jianxin Wang China 19 1.1k 1.4× 359 1.0× 407 1.1× 245 1.3× 114 0.9× 32 1.8k
Aeju Lee South Korea 23 681 0.9× 401 1.1× 569 1.6× 101 0.6× 160 1.3× 38 1.4k
Huining He China 19 573 0.8× 530 1.5× 499 1.4× 112 0.6× 124 1.0× 44 1.3k
Ying Xie China 17 621 0.8× 290 0.8× 216 0.6× 84 0.5× 113 0.9× 55 1.1k
Behrooz Johari Iran 23 498 0.7× 317 0.9× 413 1.2× 68 0.4× 284 2.3× 72 1.3k
Meng Zhou China 20 890 1.2× 450 1.3× 349 1.0× 415 2.3× 261 2.1× 46 1.9k
Chunxiong Zheng China 20 667 0.9× 321 0.9× 464 1.3× 203 1.1× 136 1.1× 34 1.3k
Alexandros Marios Sofias Germany 17 494 0.7× 447 1.2× 505 1.4× 164 0.9× 135 1.1× 32 1.2k
Lifang Cheng China 18 770 1.0× 397 1.1× 389 1.1× 297 1.6× 149 1.2× 32 1.3k
Dafeng Chu China 13 534 0.7× 403 1.1× 717 2.0× 442 2.4× 94 0.8× 16 1.3k

Countries citing papers authored by Shiyan Dong

Since Specialization
Citations

This map shows the geographic impact of Shiyan Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiyan Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiyan Dong more than expected).

Fields of papers citing papers by Shiyan Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiyan Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiyan Dong. The network helps show where Shiyan Dong may publish in the future.

Co-authorship network of co-authors of Shiyan Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Shiyan Dong. A scholar is included among the top collaborators of Shiyan Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiyan Dong. Shiyan Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schrank, Benjamin R., Yifan Wang, DaeYong Lee, et al.. (2025). An antibody–toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy. Nature Cancer. 6(3). 511–527. 9 indexed citations
2.
Zhang, Xueyan, Shiyan Dong, Huan Zhang, et al.. (2024). The size-switchable microspheres co-loaded with RANK siRNA and salmon calcitonin for osteoporosis therapy. Chinese Chemical Letters. 35(12). 109668–109668.
3.
Yang, Ling, Adam Grippin, Yifan Ma, et al.. (2024). Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles. Nature Communications. 15(1). 3987–3987. 18 indexed citations
4.
Ma, Yifan, Shiyan Dong, Adam Grippin, et al.. (2024). Engineering therapeutical extracellular vesicles for clinical translation. Trends in biotechnology. 43(1). 61–82. 49 indexed citations
5.
Chang, Mengyu, Man Wang, Bin Liu, et al.. (2024). A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy. ACS Nano. 18(11). 8143–8156. 19 indexed citations
6.
Sun, Lili, Haoyi Niu, Yuqiong Wu, et al.. (2024). Bio-integrated scaffold facilitates large bone regeneration dominated by endochondral ossification. Bioactive Materials. 35. 208–227. 13 indexed citations
7.
Huntoon, Kristin, et al.. (2023). Targeting phagocytosis to enhance antitumor immunity. Trends in cancer. 9(8). 650–665. 9 indexed citations
8.
Li, Xuefeng, Kristin Huntoon, Yifan Wang, et al.. (2023). Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity. Molecular Cancer Therapeutics. 23(3). 330–342. 2 indexed citations
9.
Li, Jun, Chao Xue, Hao Wang, et al.. (2022). Hybrid Nanofibrous Composites with Anisotropic Mechanics and Architecture for Tendon/Ligament Repair and Regeneration. Small. 18(27). e2201147–e2201147. 19 indexed citations
10.
Lü, Yifei, Kristin Huntoon, DaeYong Lee, et al.. (2022). Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy. Nature Nanotechnology. 17(12). 1332–1341. 48 indexed citations
11.
Liu, Xin, Shiyan Dong, Yuan Li, et al.. (2021). Transferrin-conjugated liposomes loaded with carnosic acid inhibit liver cancer growth by inducing mitochondria-mediated apoptosis. International Journal of Pharmaceutics. 607. 121034–121034. 20 indexed citations
12.
Wu, Kang, Jinduan Lin, Yuan Liu, et al.. (2021). Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?. Frontiers in Pharmacology. 12. 695957–695957. 20 indexed citations
13.
Ma, Yifan, Shiyan Dong, Xuefeng Li, et al.. (2021). Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy. Frontiers in Oncology. 10. 606906–606906. 58 indexed citations
14.
Gong, Ping, Yifan Wang, Pengfei Zhang, et al.. (2020). Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy. Cancers. 13(1). 77–77. 75 indexed citations
15.
Wang, Lixuan, Shiyan Dong, Yutong Liu, et al.. (2020). Fabrication of Injectable, Porous Hyaluronic Acid Hydrogel Based on an In-Situ Bubble-Forming Hydrogel Entrapment Process. Polymers. 12(5). 1138–1138. 33 indexed citations
16.
Yan, Lina, et al.. (2020). Nanoparticle-Based Drug Delivery System: A Patient-Friendly Chemotherapy for Oncology. Dose-Response. 18(3). 3584384993–3584384993. 135 indexed citations
17.
Hao, Fei, Robert J. Lee, Shiyan Dong, et al.. (2019). Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy. Theranostics. 9(18). 5282–5297. 44 indexed citations
18.
Zhao, Yarong, Robert J. Lee, Shiyan Dong, et al.. (2019). Multifunctional drug carrier based on PEI derivatives loaded with small interfering RNA for therapy of liver cancer. International Journal of Pharmaceutics. 564. 214–224. 26 indexed citations
19.
Sun, Xiangshi, Shiyan Dong, Xiangyu Li, et al.. (2019). Delivery of siRNA using folate receptor-targeted pH-sensitive polymeric nanoparticles for rheumatoid arthritis therapy. Nanomedicine Nanotechnology Biology and Medicine. 20. 102017–102017. 67 indexed citations
20.
Zhao, Yarong, Shiyan Dong, Yating Sun, et al.. (2018). Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood–Brain Barrier. Anticancer Research. 39(1). 237–243. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026